QUEBEC CITY, Aug. 6 /CNW Telbec/ - AEterna Zentaris Inc. (NASDAQ: AEZS,
TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and
oncology, today announced that its President and CEO, Juergen Engel, Ph.D.,
will present a corporate overview at the upcoming Canaccord Adams 29th Annual
Global Growth Conference on Wednesday, August 12, 2009 at 2:00 p.m. (eastern
time) at the Intercontinental Hotel in Boston.
A live webcast of the presentation will be available on AEterna Zentaris'
website at www.aezsinc.com in the Investors section. A replay will also be
available for a period of 30 days on the Company's website.
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is a global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug discovery,
development and commercialization. News releases and additional information
are available at www.aezsinc.com.
For further information:
For further information: Investor Relations: Ginette Vallières, Investor
Relations Coordinator, (418) 652-8525 ext. 265, email@example.com; Media
Relations: Paul Burroughs, Director of Communications, (418) 652-8525 ext.